TScan Therapeutics (TCRX) Shares Outstanding (2020 - 2026)
TScan Therapeutics (TCRX) Shares Outstanding (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 132.89 Mn |
| 10 | TScan Therapeutics | 102.89 Mn | -25.17 Mn | - | 129.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.91 Mn |
| Dec 31, 2025 | 129.78 Mn |
| Sep 30, 2025 | 129.84 Mn |
| Jun 30, 2025 | 129.73 Mn |
| Mar 31, 2025 | 129.68 Mn |
| Dec 31, 2024 | 111.99 Mn |
| Sep 30, 2024 | 118.70 Mn |
| Jun 30, 2024 | 113.43 Mn |
| Mar 31, 2024 | 94.88 Mn |
| Dec 31, 2023 | 65.60 Mn |
| Sep 30, 2023 | 94.83 Mn |
| Jun 30, 2023 | 47.21 Mn |
| Mar 31, 2023 | 24.23 Mn |
| Dec 31, 2022 | 24.05 Mn |
| Sep 30, 2022 | 24.07 Mn |
| Jun 30, 2022 | 24.06 Mn |
| Mar 31, 2022 | 23.97 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 19.88 Mn |
| Jun 30, 2021 | 1.39 Mn |